EastWest Bioscience Inc., headquartered in California, is a prominent player in the health and wellness industry, specialising in the development and distribution of innovative natural health products. Founded in 2016, the company has quickly established itself as a leader in the market, focusing on high-quality nutraceuticals and dietary supplements that cater to a growing consumer demand for holistic health solutions. With a diverse portfolio that includes unique formulations of vitamins, minerals, and herbal extracts, EastWest Bioscience stands out for its commitment to quality and sustainability. The company’s operational reach extends across North America, where it has garnered a reputation for excellence and reliability. Notable achievements include strategic partnerships and a robust distribution network, positioning EastWest Bioscience as a trusted name in the natural health sector.
How does EastWest Bioscience Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
EastWest Bioscience Inc.'s score of 14 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
EastWest Bioscience Inc., headquartered in California, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate climate impact. However, without specific emissions data or commitments, EastWest Bioscience Inc. appears to be at a nascent stage in its climate strategy. As the global focus on climate action intensifies, it may be beneficial for the company to consider developing measurable targets and initiatives to align with industry standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
EastWest Bioscience Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
